The AXIOS Electrocautery-Enhanced Stent and Delivery System is designed to enable endoscopic drainage of pancreatic pseudocysts or walled-off necrosis through transgastric or transduodenal access.

ABSTRACT: Therapeutic individualization in menopause requires a careful assessment of risks, benefits, and patient preferences within a context of increasing diversity of available treatment options.

WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...

Boston Scientific Corp.'s Farapoint, its latest pulsed field ablation catheter, received U.S. FDA approval for use as an adjunctive device when treating persistent atrial fibrillation that requires ...

Boston Scientific has received Food and Drug Administration approval for a new pulsed field ablation catheter that is indicated for use as an adjunctive device in a type of ablation that is performed ...

Jan 13 (Reuters) - Gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday introduced a dataset that maps genetic changes to help accelerate drug ...

Scientific computing relies heavily on powerful tools like Julia and Python. While Python has long been the preferred choice in High Energy Physics (HEP) data analysis, there’s a growing interest in ...

The U.S. Food and Drug Administration announced a major shift in its approach to real‑world evidence (RWE). In new guidance for certain medical device submissions, FDA will accept RWE without always ...

The FDA said it plans to accept new forms of real-world evidence in product applications, starting with a subset of medical device submissions. The agency said the policy change aims to enable the use ...

TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is ...